Free Trial

KBC Group NV Raises Stake in Exelon Corporation $EXC

Exelon logo with Utilities background
Image from MarketBeat Media, LLC.

Key Points

  • KBC Group NV increased its stake in Exelon by 15% in Q4, acquiring 25,024 shares to hold 191,864 shares valued at about $8.36 million.
  • Several major brokers (Barclays, BMO, Mizuho) downgraded EXC—pressuring the stock—but other firms like Argus and Citigroup remain positive, leaving the consensus rating at a Hold with an average price target of $51.
  • Exelon raised its quarterly dividend to $0.42 (annualized $1.68, ~3.6% yield), reported an EPS beat for the quarter, and issued FY2026 guidance of $2.81–$2.91 per share.
  • MarketBeat previews the top five stocks to own by May 1st.

KBC Group NV raised its holdings in Exelon Corporation (NASDAQ:EXC - Free Report) by 15.0% during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 191,864 shares of the company's stock after acquiring an additional 25,024 shares during the period. KBC Group NV's holdings in Exelon were worth $8,363,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. LRI Investments LLC raised its holdings in shares of Exelon by 210.8% in the 3rd quarter. LRI Investments LLC now owns 578 shares of the company's stock valued at $26,000 after acquiring an additional 392 shares in the last quarter. Optima Capital LLC purchased a new stake in shares of Exelon in the 4th quarter valued at about $25,000. Beacon Financial Strategies CORP purchased a new stake in shares of Exelon in the 4th quarter valued at about $26,000. Root Financial Partners LLC purchased a new stake in shares of Exelon in the 3rd quarter valued at about $30,000. Finally, Steigerwald Gordon & Koch Inc. purchased a new stake in shares of Exelon in the 3rd quarter valued at about $32,000. Hedge funds and other institutional investors own 80.92% of the company's stock.

Exelon News Summary

Here are the key news stories impacting Exelon this week:

Exelon Price Performance

Shares of Exelon stock opened at $47.02 on Friday. The company has a current ratio of 0.92, a quick ratio of 0.84 and a debt-to-equity ratio of 1.66. The firm has a market capitalization of $48.11 billion, a PE ratio of 17.22, a price-to-earnings-growth ratio of 2.76 and a beta of 0.41. The business's 50-day moving average price is $48.33 and its 200-day moving average price is $46.28. Exelon Corporation has a 12 month low of $41.71 and a 12 month high of $50.65.

Exelon (NASDAQ:EXC - Get Free Report) last announced its quarterly earnings data on Thursday, February 12th. The company reported $0.59 EPS for the quarter, beating the consensus estimate of $0.55 by $0.04. Exelon had a return on equity of 9.97% and a net margin of 11.41%.Exelon's quarterly revenue was down 1.1% compared to the same quarter last year. During the same quarter last year, the firm posted $0.64 EPS. Exelon has set its FY 2026 guidance at 2.810-2.910 EPS. Sell-side analysts forecast that Exelon Corporation will post 2.64 EPS for the current fiscal year.

Exelon Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 13th. Investors of record on Monday, March 2nd were given a dividend of $0.42 per share. This represents a $1.68 annualized dividend and a yield of 3.6%. The ex-dividend date was Monday, March 2nd. This is a positive change from Exelon's previous quarterly dividend of $0.40. Exelon's dividend payout ratio is 61.54%.

Analysts Set New Price Targets

EXC has been the topic of several recent analyst reports. Jefferies Financial Group lowered their price target on Exelon from $57.00 to $55.00 and set a "buy" rating on the stock in a report on Tuesday, January 27th. Mizuho set a $48.00 price target on Exelon and gave the company a "neutral" rating in a report on Friday. Citigroup initiated coverage on Exelon in a report on Thursday, March 26th. They issued a "buy" rating and a $58.00 price target on the stock. Scotiabank raised their price target on Exelon from $46.00 to $47.00 and gave the company a "sector perform" rating in a report on Friday, February 13th. Finally, Barclays cut Exelon from an "overweight" rating to an "equal weight" rating and lowered their price target for the company from $50.00 to $49.00 in a report on Friday. Six equities research analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, the company currently has an average rating of "Hold" and an average price target of $51.00.

Check Out Our Latest Stock Report on EXC

Exelon Profile

(Free Report)

Exelon Corporation NASDAQ: EXC is a Chicago-based energy company that operates primarily as a regulated electric and natural gas utility holding company. The company's businesses focus on the delivery of electricity and related services to residential, commercial and industrial customers, as well as investments in grid modernization, customer energy solutions and demand-side programs. Exelon's operations emphasize reliable service delivery, infrastructure maintenance and regulatory compliance across its utility footprint.

Formed in 2000 through the merger of Unicom and PECO Energy, Exelon historically combined generation and regulated utility businesses.

Read More

Want to see what other hedge funds are holding EXC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Exelon Corporation (NASDAQ:EXC - Free Report).

Institutional Ownership by Quarter for Exelon (NASDAQ:EXC)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Exelon Right Now?

Before you consider Exelon, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exelon wasn't on the list.

While Exelon currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines